Stimulation of human immunodeficiency virus type 1 (HIV-1) specific cytolytic effector function using allogeneic cell immunotherapy [ 2012 - 2015 ]

Research Grant

[Cite as]

Researchers: A/Pr Lloyd D'Orsogna (Principal investigator) ,  A/Pr Campbell Witt

Brief description A preventative HIV vaccine is not currently available. Stimulation of the bodies own immune cells (T-cells) may be associated with better protection against the virus, and we have recently discovered that T-cells already present in humans are frequently stimulated by foreign (allogeneic) cells. Therefore we aim to determine if “vaccination” with allogeneic cells could stimulate a HIV specific immune response in humans. These results could have important implications for HIV vaccine design.

Funding Amount $AUD 377,648.35

Funding Scheme Project Grants

Notes New Investigator Grant

Viewed: [[ro.stat.viewed]]